Treating Anal HSIL Cuts Anal Cancer Risk in Persons With HIV
Rate of progression to anal cancer lower for those receiving treatment of anal high-grade squamous intraepithelial lesions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.